Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366338876> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4366338876 endingPage "216" @default.
- W4366338876 startingPage "214" @default.
- W4366338876 abstract "Background: The cancer antigen 125 “CA125” and Human Epididymis protein 4 “HE4” are among some well worked out markers for recognition of malignancy in ovarian tumors. Their different cutoffs are determined and reported by various studies and mostly used recommended cutoffs are 35.0 U/mL for CA125 and 140pmol/L for HE4. They are both reported to recognize the malignancy well, but how specific they are for benign gynecological diseases is still needed to be worked out. Aim: To determine and compare the performance of CA125 and HE4 for benign gynecological pathologies. Methodology: A cross-sectional study was performed at Gajju Khan Medical College in collaboration with Armed forces Institute of pathology (AFIP). A total of 76 women of age above 18 years age, with benign ovarian pathology, confirmed through histological evaluation were enrolled. All these were examined on both markers, i.e. CA125 and HE4. Standard cutoffs of CA125 >35.0 U/mL and HE4>140 pmol/L were used to see if the case was labeled malignant, incorrectly. SPSS 20.0 was used to manage and analyze the data. Performance of the two markers were compared by using some descriptive analysis and using chi-square test. P-value ≤0.05 was considered significant. Results: The median age of these women was 40 years ranging between 18 and 71. Majority (86.8%) was premenopausal, The CA125 had no difference between pre and post-menopausal women but HE4 had a significant difference with p-value 0.029. there were 10.5% incorrect labeling of malignancy when evaluated for CA125, while only 2.6% incorrect on HE4. This difference was found statistically significant between two markers with p-value 0.05. Conclusion: HE4 is better and more specific marker for benign gynecological pathologies as compared to CA125 Keywords:Benign Ovarian Epithelial, Human epididymisprotein (HE4), Cancer Antigen 125 (CA125), Specificity" @default.
- W4366338876 created "2023-04-20" @default.
- W4366338876 creator A5001512805 @default.
- W4366338876 creator A5043237640 @default.
- W4366338876 creator A5048071515 @default.
- W4366338876 creator A5064607417 @default.
- W4366338876 creator A5073782256 @default.
- W4366338876 creator A5084520999 @default.
- W4366338876 date "2023-03-24" @default.
- W4366338876 modified "2023-09-26" @default.
- W4366338876 title "Is Serum Human Epididymis Protein HE4, More Specific than Cancer Antigen 125 in Patients with Benign Gynecological Diseases?" @default.
- W4366338876 doi "https://doi.org/10.53350/pjmhs2023173214" @default.
- W4366338876 hasPublicationYear "2023" @default.
- W4366338876 type Work @default.
- W4366338876 citedByCount "0" @default.
- W4366338876 crossrefType "journal-article" @default.
- W4366338876 hasAuthorship W4366338876A5001512805 @default.
- W4366338876 hasAuthorship W4366338876A5043237640 @default.
- W4366338876 hasAuthorship W4366338876A5048071515 @default.
- W4366338876 hasAuthorship W4366338876A5064607417 @default.
- W4366338876 hasAuthorship W4366338876A5073782256 @default.
- W4366338876 hasAuthorship W4366338876A5084520999 @default.
- W4366338876 hasBestOaLocation W43663388761 @default.
- W4366338876 hasConcept C121608353 @default.
- W4366338876 hasConcept C126322002 @default.
- W4366338876 hasConcept C142724271 @default.
- W4366338876 hasConcept C143998085 @default.
- W4366338876 hasConcept C147483822 @default.
- W4366338876 hasConcept C16685009 @default.
- W4366338876 hasConcept C203014093 @default.
- W4366338876 hasConcept C2779399171 @default.
- W4366338876 hasConcept C2780427987 @default.
- W4366338876 hasConcept C2781087480 @default.
- W4366338876 hasConcept C2781254305 @default.
- W4366338876 hasConcept C2781447364 @default.
- W4366338876 hasConcept C29456083 @default.
- W4366338876 hasConcept C2992389814 @default.
- W4366338876 hasConcept C71924100 @default.
- W4366338876 hasConcept C90924648 @default.
- W4366338876 hasConceptScore W4366338876C121608353 @default.
- W4366338876 hasConceptScore W4366338876C126322002 @default.
- W4366338876 hasConceptScore W4366338876C142724271 @default.
- W4366338876 hasConceptScore W4366338876C143998085 @default.
- W4366338876 hasConceptScore W4366338876C147483822 @default.
- W4366338876 hasConceptScore W4366338876C16685009 @default.
- W4366338876 hasConceptScore W4366338876C203014093 @default.
- W4366338876 hasConceptScore W4366338876C2779399171 @default.
- W4366338876 hasConceptScore W4366338876C2780427987 @default.
- W4366338876 hasConceptScore W4366338876C2781087480 @default.
- W4366338876 hasConceptScore W4366338876C2781254305 @default.
- W4366338876 hasConceptScore W4366338876C2781447364 @default.
- W4366338876 hasConceptScore W4366338876C29456083 @default.
- W4366338876 hasConceptScore W4366338876C2992389814 @default.
- W4366338876 hasConceptScore W4366338876C71924100 @default.
- W4366338876 hasConceptScore W4366338876C90924648 @default.
- W4366338876 hasIssue "3" @default.
- W4366338876 hasLocation W43663388761 @default.
- W4366338876 hasOpenAccess W4366338876 @default.
- W4366338876 hasPrimaryLocation W43663388761 @default.
- W4366338876 hasRelatedWork W2361777917 @default.
- W4366338876 hasRelatedWork W2365661089 @default.
- W4366338876 hasRelatedWork W2365770613 @default.
- W4366338876 hasRelatedWork W2380339449 @default.
- W4366338876 hasRelatedWork W2392434691 @default.
- W4366338876 hasRelatedWork W2405887092 @default.
- W4366338876 hasRelatedWork W2766607065 @default.
- W4366338876 hasRelatedWork W2941092359 @default.
- W4366338876 hasRelatedWork W2981443309 @default.
- W4366338876 hasRelatedWork W4289531758 @default.
- W4366338876 hasVolume "17" @default.
- W4366338876 isParatext "false" @default.
- W4366338876 isRetracted "false" @default.
- W4366338876 workType "article" @default.